Literature DB >> 31506303

Nusinersen for Type 1 Spinal Muscular Atrophy: A Father's Perspective.

Nathan R Hoot1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31506303     DOI: 10.1542/peds.2019-0226

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  2 in total

Review 1.  Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders.

Authors:  Sophie F Hill; Miriam H Meisler
Journal:  Dev Neurosci       Date:  2021-08-05       Impact factor: 3.421

Review 2.  Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment.

Authors:  Giovanna Menduti; Daniela Maria Rasà; Serena Stanga; Marina Boido
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.